117 related articles for article (PubMed ID: 34062264)
1. Curing pancreatic cancer.
Traub B; Link KH; Kornmann M
Semin Cancer Biol; 2021 Nov; 76():232-246. PubMed ID: 34062264
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer from bench to bedside: molecular pathways and treatment options.
Kosmidis C; Sapalidis K; Kotidis E; Mixalopoulos N; Zarogoulidis P; Tsavlis D; Baka S; Man YG; Kanellos J
Ann Transl Med; 2016 May; 4(9):165. PubMed ID: 27275478
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Cancer: A Review.
Park W; Chawla A; O'Reilly EM
JAMA; 2021 Sep; 326(9):851-862. PubMed ID: 34547082
[TBL] [Abstract][Full Text] [Related]
4. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
5. The pancreatic cancer genome revisited.
Hayashi A; Hong J; Iacobuzio-Donahue CA
Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):469-481. PubMed ID: 34089011
[TBL] [Abstract][Full Text] [Related]
6. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H
Front Immunol; 2021; 12():769425. PubMed ID: 34804059
[TBL] [Abstract][Full Text] [Related]
8. New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting.
Hessmann E; Schneider G;
Gastroenterology; 2021 Sep; 161(3):785-791. PubMed ID: 34089734
[TBL] [Abstract][Full Text] [Related]
9. Role of RNA methylation in the regulation of pancreatic cancer stem cells (Review).
Tsuji Y; Hara T; Meng S; Sato H; Arao Y; Ofusa K; Ishii H
Oncol Lett; 2023 Aug; 26(2):336. PubMed ID: 37427348
[TBL] [Abstract][Full Text] [Related]
10. The emerging roles and mechanism of N6-methyladenosine (m
Zhu W; Zhao R; Guan X; Wang X
Front Pharmacol; 2023; 14():1192495. PubMed ID: 37284313
[TBL] [Abstract][Full Text] [Related]
11. Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential.
Zhu TY; Hong LL; Ling ZQ
Biomark Res; 2023 Jun; 11(1):62. PubMed ID: 37280679
[TBL] [Abstract][Full Text] [Related]
12. Systemic Analyses of Cuproptosis-Related lncRNAs in Pancreatic Adenocarcinoma, with a Focus on the Molecular Mechanism of LINC00853.
Chen L; Zhang L; He H; Shao F; Gao Y; He J
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175629
[TBL] [Abstract][Full Text] [Related]
13. m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis.
Jiang X; Jin Z; Yang Y; Zheng X; Chen S; Wang S; Zhang X; Qu N
Front Oncol; 2023; 13():1162300. PubMed ID: 37152066
[TBL] [Abstract][Full Text] [Related]
14. Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer.
Yao HF; Xu DP; Zheng JH; Xu Y; Jia QY; Zhu YH; Yang J; He RZ; Ma D; Yang MW; Fu XL; Liu DJ; Huo YM; Yang JY; Zhang JF
Apoptosis; 2023 Aug; 28(7-8):1090-1112. PubMed ID: 37079192
[TBL] [Abstract][Full Text] [Related]
15. METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.
Lin C; Li T; Wang Y; Lai S; Huang Y; Guo Z; Zhang X; Weng S
Cell Death Dis; 2023 Mar; 14(3):221. PubMed ID: 36977668
[TBL] [Abstract][Full Text] [Related]
16. COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bioinformatics and Experimental Validation.
Song Y; Wang L; Wang K; Lu Y; Zhou P
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900272
[TBL] [Abstract][Full Text] [Related]
17. Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance.
Jo H; Shim K; Jeoung D
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835633
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer.
Song Z; Wang X; Chen F; Chen Q; Liu W; Yang X; Zhu X; Liu X; Wang P
Front Oncol; 2022; 12():1004212. PubMed ID: 36212476
[TBL] [Abstract][Full Text] [Related]
19. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
20. Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma.
Wu Z; Huang X; Cai M; Huang P; Guan Z
Aging (Albany NY); 2022 Jan; 14(2):869-891. PubMed ID: 35077391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
